The role of Bcl-2 family members in tumorigenesis

被引:467
作者
Kirkin, V [1 ]
Joos, S [1 ]
Zörnig, M [1 ]
机构
[1] Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 2004年 / 1644卷 / 2-3期
关键词
Bcl-2; family; tumorigenesis; cell cycle; chemoresistance; radiation; clinical therapy;
D O I
10.1016/j.bbamcr.2003.08.009
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Bcl-2 family consists of about 20 homologues of important pro- and anti-apoptotic regulators of programmed cell death. The established mode of function of the individual members is to either preserve or disturb mitochondrial integrity, thereby inducing or preventing release of apoptogenic factors like Cytochrome c (Cyt c) from mitochondria. Recent findings also indicate further Bcl-2-controlled mitochondria-independent apoptosis pathways. Bcl-2 represents the founding member of the new and growing class of cell death inhibiting oncoproteins. In this review, we try to briefly summarize current models of Bcl-2 family function and to outline the work demonstrating the influence of deregulated Bcl-2 family member expression on tumorigenesis and cancer therapy. Since several Bcl-2 homologues, in addition to influencing apoptotic behaviour, also impinge on cell cycle progression, we discuss possible implications of this additional role for the expression of Bcl-2 family members in tumor cells. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:229 / 249
页数:21
相关论文
共 246 条
[61]   BCL-xL and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinases [J].
Greider, C ;
Chattopadhyay, A ;
Parkhurst, C ;
Yang, E .
ONCOGENE, 2002, 21 (51) :7765-7775
[62]   Cell damage-induced conformational changes of the pro-apoptotic protein bak in vivo precede the onset of apoptosis [J].
Griffiths, GJ ;
Dubrez, L ;
Morgan, CP ;
Jones, NA ;
Whitehouse, J ;
Corfe, BM ;
Dive, C ;
Hickman, JA .
JOURNAL OF CELL BIOLOGY, 1999, 144 (05) :903-914
[63]   tBID homooligomerizes in the mitochondrial membrane to induce apoptosis [J].
Grinberg, M ;
Sarig, R ;
Zaltsman, Y ;
Frumkin, D ;
Grammatikakis, N ;
Reuveny, E ;
Gross, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (14) :12237-12245
[64]   Molecular mechanisms of "detachment-induced apoptosis-Anoikis" [J].
Grossmann, J .
APOPTOSIS, 2002, 7 (03) :247-260
[65]   Apoptotic crosstalk between the endoplasmic reticulum and mitochondria controlled by Bcl-2 [J].
Häcki, J ;
Egger, L ;
Monney, L ;
Conus, S ;
Rossé, T ;
Fellay, I ;
Borner, C .
ONCOGENE, 2000, 19 (19) :2286-2295
[66]   The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70
[67]   Hypoxia - A key regulatory factor in tumour growth [J].
Harris, AL .
NATURE REVIEWS CANCER, 2002, 2 (01) :38-47
[68]   Bcl-xL is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy [J].
Heere-Ress, E ;
Thallinger, C ;
Lucas, T ;
Schlagbauer-Wadl, H ;
Wacheck, V ;
Monia, BP ;
Wolff, K ;
Pehamberger, H ;
Jansen, B .
INTERNATIONAL JOURNAL OF CANCER, 2002, 99 (01) :29-34
[69]   The structure of Bcl-w reveals a role for the C-terminal residues in modulating biological activity [J].
Hinds, MG ;
Lackmann, M ;
Skea, GL ;
Harrison, PJ ;
Huang, DCS ;
Day, CL .
EMBO JOURNAL, 2003, 22 (07) :1497-1507
[70]   BCL-2 IS AN INNER MITOCHONDRIAL-MEMBRANE PROTEIN THAT BLOCKS PROGRAMMED CELL-DEATH [J].
HOCKENBERY, D ;
NUNEZ, G ;
MILLIMAN, C ;
SCHREIBER, RD ;
KORSMEYER, SJ .
NATURE, 1990, 348 (6299) :334-336